Canaan Partners Xi is an investment fund managing more than $82.6 billion ran by Nancy Levenson. There are currently 3 companies in Mrs. Levenson’s portfolio. The largest investments include Tyra Biosciences Inc and Aeva Technologies Inc, together worth $79.8 billion.
As of 2nd July 2024, Canaan Partners Xi’s top holding is 4,409,991 shares of Tyra Biosciences Inc currently worth over $70.5 billion and making up 85.4% of the portfolio value.
In addition, the fund holds 3,697,039 shares of Aeva Technologies Inc worth $9.32 billion.
The third-largest holding is Rallybio Corp worth $2.76 billion.
Currently, Canaan Partners Xi's portfolio is worth at least $82.6 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Canaan Partners Xi office and employees reside in Menlo Park, California. According to the last 13-F report filed with the SEC, Nancy Levenson serves as the Attorney-in-Fact at Canaan Partners Xi.
The two most similar investment funds to Canaan Partners Xi are Oslo Asset Management As and Triad Investment Management. They manage $82.5 billion and $82.4 billion respectively.
These positions were updated on July 9th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Tyra Biosciences Inc |
No change
4,409,991
|
$70,515,756,000 | 85.38% |
| Aeva Technologies Inc |
No change
3,697,039
|
$9,316,538,000 | 11.28% |
| Rallybio Corp |
No change
2,059,712
|
$2,760,014,000 | 3.34% |
| No transactions found | |||
| Showing first 500 out of 3 holdings | |||